TNF Pharmaceuticals - TNFA Operating Profitability

TNFA (TNF Pharmaceuticals Inc.) - company brandmark

TNF Pharmaceuticals adheres to environmental standards in its laboratories by minimizing bio-waste. TNF Pharmaceuticals is developing unique anti-inflammatory methods, competing through its patent portfolio. However, the lack of stable revenue and the risks of failed tests create a threat of devaluation. The GURU.Markets terminal displays a chart of the core business margin, where 0.00 reflects the latest metric value, helping to assess the business's resilience.

TNFA: TNF Pharmaceuticals Inc. Operating Profit Rate 07/25/2024 - 09/25/2025

TNF Pharma - analytical breakdowns and key metrics (TNFA)

- stock quotes and analyst forecast:
Comprehensive company analysis:tnfpharma.com, TNFA
Core merchandise of TNF Pharmaceuticals Inc.

This indicator measures the share of operating profit in total revenue, allowing for an assessment of production process efficiency before accounting for debt obligations and taxes. An analysis of the core business margin reveals a critical gap between R&D expenditures and the lack of commercial products from TNF Pharmaceuticals (TNFA), which renders current operating efficiency negative due to the specific nature of a biotechnology startup.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability Impact BioMedical Inc|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.